Treatment of Acinetobacter Infections
Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose resistance patterns result in significant challenges for the clinician. Despite the prevalence and interest in A. baumannii infections, there is relatively limited wellcontrolled scientific data to help the clinician...
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 2010-07, Vol.51 (1), p.79-84 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 84 |
|---|---|
| container_issue | 1 |
| container_start_page | 79 |
| container_title | Clinical infectious diseases |
| container_volume | 51 |
| creator | Fishbain, Joel Peleg, Anton Y. |
| description | Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose resistance patterns result in significant challenges for the clinician. Despite the prevalence and interest in A. baumannii infections, there is relatively limited wellcontrolled scientific data to help the clinician select optimal empirical and subsequent targeted therapy for a variety of infections. We will review the currently available antimicrobial agents and discuss the clinical data supporting the use of the various agents. |
| doi_str_mv | 10.1086/653120 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_754543013</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>25679965</jstor_id><oup_id>10.1086/653120</oup_id><sourcerecordid>25679965</sourcerecordid><originalsourceid>FETCH-LOGICAL-c453t-3b136d85201ea639ff3f760b3ce9a8c279c8940813d792592e0a781de9b47c563</originalsourceid><addsrcrecordid>eNqF0F1LwzAUBuAgih9T_4EyBfWqmvTk81KHOmUgiIJ4E9Ishc6tmUkK-u_t6HQgiFcJnIc3Jy9C-wSfEyz5BWdAcryGtgkDkXGmyHp7x0xmVILcQjsxTjAmRGK2ibZyzDDNgW6jk6fgTJq5OvV92b-0Ve2SL4xNLvTv6tLZVPk67qKN0kyj21uePfR8c_00GGajh9u7weUos5RByqAgwMeS5Zg4w0GVJZSC4wKsU0baXCgrFcWSwFionKncYSMkGTtVUGEZhx4663Lnwb83LiY9q6J106mpnW-iFowyCpjA_xKAgKBikXn8S058E-r2Gxo4B2g3WcSddsgGH2NwpZ6HambCpyZYLwrWXcEtPFymNcXMjX_Yd6MtOFkCE62ZlsHUtoorlyss2v1bd9Q538z_fuygM5OYfFhlMC6Uak0PZd28isl9_MxNeNNcgGB6-PKqH2_uQQ1HVF_BF8JioGM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>366337923</pqid></control><display><type>article</type><title>Treatment of Acinetobacter Infections</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Fishbain, Joel ; Peleg, Anton Y.</creator><contributor>Saravolatz, LD</contributor><creatorcontrib>Fishbain, Joel ; Peleg, Anton Y. ; Saravolatz, LD</creatorcontrib><description>Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose resistance patterns result in significant challenges for the clinician. Despite the prevalence and interest in A. baumannii infections, there is relatively limited wellcontrolled scientific data to help the clinician select optimal empirical and subsequent targeted therapy for a variety of infections. We will review the currently available antimicrobial agents and discuss the clinical data supporting the use of the various agents.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/653120</identifier><identifier>PMID: 20504234</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Oxford: The University of Chicago Press</publisher><subject>Acinetobacter ; Acinetobacter baumannii ; Acinetobacter baumannii - drug effects ; Acinetobacter Infections - drug therapy ; Aminoglycosides ; Anti-Infective Agents - therapeutic use ; Antibiotics ; Antimicrobial agents ; Biological and medical sciences ; Carbapenems ; Dosage ; Drug resistance ; Drug Resistance, Bacterial ; Drug Therapy, Combination ; Gram-negative bacteria ; Humans ; Infections ; Infectious diseases ; Medical sciences ; Mortality ; Pathogens ; Polymyxins ; REVIEWS OF ANTI-INFECTIVE AGENTS</subject><ispartof>Clinical infectious diseases, 2010-07, Vol.51 (1), p.79-84</ispartof><rights>2010 Infectious Diseases Society of America</rights><rights>2010 by the Infectious Diseases Society of America 2010</rights><rights>2015 INIST-CNRS</rights><rights>Copyright University of Chicago, acting through its Press Jul 1, 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c453t-3b136d85201ea639ff3f760b3ce9a8c279c8940813d792592e0a781de9b47c563</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/25679965$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/25679965$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22907133$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20504234$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Saravolatz, LD</contributor><creatorcontrib>Fishbain, Joel</creatorcontrib><creatorcontrib>Peleg, Anton Y.</creatorcontrib><title>Treatment of Acinetobacter Infections</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose resistance patterns result in significant challenges for the clinician. Despite the prevalence and interest in A. baumannii infections, there is relatively limited wellcontrolled scientific data to help the clinician select optimal empirical and subsequent targeted therapy for a variety of infections. We will review the currently available antimicrobial agents and discuss the clinical data supporting the use of the various agents.</description><subject>Acinetobacter</subject><subject>Acinetobacter baumannii</subject><subject>Acinetobacter baumannii - drug effects</subject><subject>Acinetobacter Infections - drug therapy</subject><subject>Aminoglycosides</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Biological and medical sciences</subject><subject>Carbapenems</subject><subject>Dosage</subject><subject>Drug resistance</subject><subject>Drug Resistance, Bacterial</subject><subject>Drug Therapy, Combination</subject><subject>Gram-negative bacteria</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Mortality</subject><subject>Pathogens</subject><subject>Polymyxins</subject><subject>REVIEWS OF ANTI-INFECTIVE AGENTS</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0F1LwzAUBuAgih9T_4EyBfWqmvTk81KHOmUgiIJ4E9Ishc6tmUkK-u_t6HQgiFcJnIc3Jy9C-wSfEyz5BWdAcryGtgkDkXGmyHp7x0xmVILcQjsxTjAmRGK2ibZyzDDNgW6jk6fgTJq5OvV92b-0Ve2SL4xNLvTv6tLZVPk67qKN0kyj21uePfR8c_00GGajh9u7weUos5RByqAgwMeS5Zg4w0GVJZSC4wKsU0baXCgrFcWSwFionKncYSMkGTtVUGEZhx4663Lnwb83LiY9q6J106mpnW-iFowyCpjA_xKAgKBikXn8S058E-r2Gxo4B2g3WcSddsgGH2NwpZ6HambCpyZYLwrWXcEtPFymNcXMjX_Yd6MtOFkCE62ZlsHUtoorlyss2v1bd9Q538z_fuygM5OYfFhlMC6Uak0PZd28isl9_MxNeNNcgGB6-PKqH2_uQQ1HVF_BF8JioGM</recordid><startdate>20100701</startdate><enddate>20100701</enddate><creator>Fishbain, Joel</creator><creator>Peleg, Anton Y.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20100701</creationdate><title>Treatment of Acinetobacter Infections</title><author>Fishbain, Joel ; Peleg, Anton Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c453t-3b136d85201ea639ff3f760b3ce9a8c279c8940813d792592e0a781de9b47c563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Acinetobacter</topic><topic>Acinetobacter baumannii</topic><topic>Acinetobacter baumannii - drug effects</topic><topic>Acinetobacter Infections - drug therapy</topic><topic>Aminoglycosides</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Biological and medical sciences</topic><topic>Carbapenems</topic><topic>Dosage</topic><topic>Drug resistance</topic><topic>Drug Resistance, Bacterial</topic><topic>Drug Therapy, Combination</topic><topic>Gram-negative bacteria</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Mortality</topic><topic>Pathogens</topic><topic>Polymyxins</topic><topic>REVIEWS OF ANTI-INFECTIVE AGENTS</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fishbain, Joel</creatorcontrib><creatorcontrib>Peleg, Anton Y.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fishbain, Joel</au><au>Peleg, Anton Y.</au><au>Saravolatz, LD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of Acinetobacter Infections</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2010-07-01</date><risdate>2010</risdate><volume>51</volume><issue>1</issue><spage>79</spage><epage>84</epage><pages>79-84</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose resistance patterns result in significant challenges for the clinician. Despite the prevalence and interest in A. baumannii infections, there is relatively limited wellcontrolled scientific data to help the clinician select optimal empirical and subsequent targeted therapy for a variety of infections. We will review the currently available antimicrobial agents and discuss the clinical data supporting the use of the various agents.</abstract><cop>Oxford</cop><pub>The University of Chicago Press</pub><pmid>20504234</pmid><doi>10.1086/653120</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 2010-07, Vol.51 (1), p.79-84 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_754543013 |
| source | MEDLINE; JSTOR Archive Collection A-Z Listing; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Acinetobacter Acinetobacter baumannii Acinetobacter baumannii - drug effects Acinetobacter Infections - drug therapy Aminoglycosides Anti-Infective Agents - therapeutic use Antibiotics Antimicrobial agents Biological and medical sciences Carbapenems Dosage Drug resistance Drug Resistance, Bacterial Drug Therapy, Combination Gram-negative bacteria Humans Infections Infectious diseases Medical sciences Mortality Pathogens Polymyxins REVIEWS OF ANTI-INFECTIVE AGENTS |
| title | Treatment of Acinetobacter Infections |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T19%3A24%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20Acinetobacter%20Infections&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Fishbain,%20Joel&rft.date=2010-07-01&rft.volume=51&rft.issue=1&rft.spage=79&rft.epage=84&rft.pages=79-84&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1086/653120&rft_dat=%3Cjstor_proqu%3E25679965%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=366337923&rft_id=info:pmid/20504234&rft_jstor_id=25679965&rft_oup_id=10.1086/653120&rfr_iscdi=true |